Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Access to essential drugs in developing countries].

P Rojo1

  • 1Departamento de Pediatría. Hospital 12 de Octubre. Madrid. Colaborador de Intermón-Oxfam.

Gaceta Sanitaria
|February 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.

British journal of clinical pharmacology·2025
Same author

Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy.

Journal of virus eradication·2018
Same author

Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2016
Same author

The EPIICAL project: an emerging global collaboration to investigate immunotherapeutic strategies in HIV-infected children.

Journal of virus eradication·2016
Same author

[Response to the letter to the editor from SEOP as regards the SEIP-SERPE-SEOP consensus document on the treatment of uncomplicated acute osteomyelitis and septic arthritis].

Anales de pediatria (Barcelona, Spain : 2003)·2015
Same author

Discovery and spectroscopy of the young jovian planet 51 Eri b with the Gemini Planet Imager.

Science (New York, N.Y.)·2015
Same journal

[New capacities and digital transformation of patients with complex chronic conditions (DAIPO). Study protocol].

Gaceta sanitaria·2026
Same journal

[Estimation of secondhand smoke exposure: the impact of question wording].

Gaceta sanitaria·2026
Same journal

[Comprehensive policies without implementation or resources: the European discrepancy on childhood obesity].

Gaceta sanitaria·2026
Same journal

[A national palliative care law in Spain: a matter of equity and public health].

Gaceta sanitaria·2026
Same journal

[The institutionalization of public health in Spain (II)].

Gaceta sanitaria·2026
Same journal

[Coordination of self-employed community healthcare professionals with the public healthcare system. SESPAS Report 2026].

Gaceta sanitaria·2026
See all related articles

Infectious diseases disproportionately affect impoverished children. Stricter patent rules hinder access to affordable generic medicines, worsening global health disparities for the poor.

Area of Science:

  • Global Health
  • Public Health Policy
  • Pharmaceutical Law

Background:

  • Infectious diseases cause millions of deaths annually, with a high burden on children in developing nations.
  • Poverty, inadequate public spending, and poor sanitation limit access to essential medicines for vulnerable populations.
  • The World Health Organization estimates 2 billion people lack access to essential medicines, a situation exacerbated by new patent regulations.

Purpose of the Study:

  • To analyze the impact of World Trade Organization (WTO) intellectual property rules on access to essential medicines in developing countries.
  • To highlight the challenges faced by low-income populations in obtaining necessary medical treatments due to patent exclusivity.
  • To examine the role of international trade agreements in global health equity.

Main Methods:

Related Experiment Videos

  • Analysis of World Trade Organization (WTO) intellectual property regulations and their implications for pharmaceutical access.
  • Review of case studies from developing countries (e.g., India, Brazil, South Africa, Kenya) affected by stricter patent rules.
  • Examination of advocacy efforts by non-governmental organizations (NGOs) promoting access to medicines.

Main Results:

  • New WTO patent rules, granting 20-year exclusivity, restrict governments' ability to permit low-cost generic drug production and importation.
  • Developing countries producing or importing generics have faced legal and political pressure from the pharmaceutical industry and developed nations.
  • International campaigns and legal challenges have resulted in limited successes for improving medicine access for the poor.

Conclusions:

  • Stricter patent rules significantly impede access to essential medicines for impoverished populations, particularly in developing countries.
  • Urgent reforms in international patent law and increased investment in research for diseases prevalent in developing regions are crucial for improving global health outcomes.
  • Continued advocacy and legal action are necessary to ensure equitable access to life-saving medications worldwide.